Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Pediatrix Medical Group, Inc. (MD)
|
Add to portfolio |
|
|
|
| Price: |
$27.70
| | Metrics |
| OS: |
83.9
|
M
| |
14
|
% ROE
|
| Market cap: |
$2.33
|
B
| |
25
|
% ROIC
|
|
Net debt:
|
$536
|
M
| |
|
|
|
EV:
|
$2.86
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
$159
|
M
| |
18.0
|
x EV/EBIT
|
| EPS |
$1.03
| |
26.9
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 1,911.2 | 1,734.0 | 1,779.8 | 1,723.1 | 3,253.4 | 3,183.2 | 2,780.0 | 2,438.9 |
| Revenue growth | 10.2% | -2.6% | 3.3% | -47.0% | 2.2% | 14.5% | 14.0% | 13.2% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 1,911.2 | 1,734.0 | 1,779.8 | 1,723.1 | 3,253.4 | 3,183.2 | 2,780.0 | 2,438.9 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| General and administrative | 263.4 | 248.9 | 244.5 | 232.2 | 385.9 | 372.6 | 305.9 | 247.5 |
| EBITA | 234.9 | 181.1 | 242.2 | 262.9 | 508.3 | 635.2 | 603.0 | 544.9 |
| EBITA margin | 12.3% | 10.4% | 13.6% | 15.3% | 15.6% | 20.0% | 21.7% | 22.3% |
| Amortization of intangibles | 8.0 | 7.6 | 7.3 | 6.8 | 52.5 | 60.3 | 42.0 | 30.1 |
| EBIT | 226.9 | 173.5 | 234.9 | 256.1 | 455.8 | 574.9 | 561.0 | 514.8 |
| EBIT margin | 11.9% | 10.0% | 13.2% | 14.9% | 14.0% | 18.1% | 20.2% | 21.1% |
| Pre-tax income | 135.2 | 7.1 | 58.8 | 166.2 | 385.7 | 513.8 | 539.7 | 508.6 |
| Income taxes | 27.2 | 16.7 | 16.6 | 44.7 | 80.2 | 189.2 | 204.0 | 191.4 |
| Tax rate | 20.1% | 234.0% | 28.2% | 26.9% | 20.8% | 36.8% | 37.8% | 37.6% |
| Earnings from continuing ops | 108.0 | -9.6 | 42.2 | -25.6 | 290.5 | 324.9 | 336.3 | 317.3 |
| Earnings from discontinued ops | 23.0 | -786.9 | -1,539.9 | 147.1 | 14.9 | | | |
| Net income | 131.0 | -796.5 | -1,497.7 | 121.5 | 305.4 | 324.9 | 336.3 | 317.3 |
| Net margin | 6.9% | -45.9% | -84.2% | 7.1% | 9.4% | 10.2% | 12.1% | 13.0% |
| |
| Diluted EPS | $1.26 | ($0.11) | $0.50 | ($0.28) | $3.13 | $3.49 | $3.58 | $3.18 |
| Shares outstanding (diluted) | 85.8 | 83.4 | 84.0 | 91.6 | 93.0 | 93.1 | 94.0 | 99.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|